TGFB1 and neoplasm: Tregs can inhibit cytotoxic CD8+ T cells (responsible for the induction of tumor cell death) through the expression of TGFβ and other modulating factors such as IL-10 and IL-35 or through the expression of the inhibitory molecule CTLA-4.